Palatin Technologies
PTN
#9923
Rank
NZ$67.99 M
Marketcap
NZ$39.93
Share price
4.59%
Change (1 day)
2,425.68%
Change (1 year)

Palatin Technologies (PTN) - Cash on Hand

Cash on Hand as of March 2025 : NZ$4.37 Million

According to Palatin Technologies's latest financial reports the company has NZ$4.37 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Palatin Technologies - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30NZ$15.62 M-12.76%
2023-06-30NZ$17.9 M-62.68%
2022-06-30NZ$47.97 M-44.15%
2021-06-30NZ$85.9 M-33.11%
2020-06-30NZ$0.12 B98.45%
2019-06-30NZ$64.71 M15.33%
2018-06-30NZ$56.11 M1.56%
2017-06-30NZ$55.25 M320.2%
2016-06-30NZ$13.14 M-67.31%
2015-06-30NZ$40.22 M189.27%
2014-06-30NZ$13.9 M-55.94%
2013-06-30NZ$31.55 M561.7%
2012-06-30NZ$4.76 M-79.06%
2011-06-30NZ$22.77 M77.69%
2010-06-30NZ$12.81 M5.12%
2009-06-30NZ$12.19 M-27.38%
2008-06-30NZ$16.79 M-61.78%
2007-06-30NZ$43.93 M-13.23%
2006-06-30NZ$50.62 M91.27%
2005-06-30NZ$26.47 M-17.06%
2004-06-30NZ$31.91 M1.08%
2003-06-30NZ$31.57 M93.16%
2002-06-30NZ$16.34 M-41.99%
2001-06-30NZ$28.17 M146.32%
2000-06-30NZ$11.44 M116.31%
1999-06-30NZ$5.28 M-36.04%
1998-06-30NZ$8.26 M-56.13%
1997-06-30NZ$18.85 M90.03%
1996-06-30NZ$9.92 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
MediciNova
MNOV
NZ$59.48 M 1,259.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ$9.74 M 122.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.93 B 44,137.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$0.47 B 10,672.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$1.17 B 26,761.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$32.22 B 736,469.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.42 B 9,530.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$14.20 B 324,574.81%๐Ÿ‡ฌ๐Ÿ‡ง UK